July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Topical Atropine Prevents Contact Lens-Induced Myopia in Guinea Pigs
Author Affiliations & Notes
  • Sarah Kochik
    Vision Science, University of California, Berkeley, Berkeley, California, United States
  • Christine Frances Wildsoet
    Vision Science, University of California, Berkeley, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Sarah Kochik, None; Christine Wildsoet, None
  • Footnotes
    Support  NEI Grant 5T32EY7043-38
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 691. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah Kochik, Christine Frances Wildsoet; Topical Atropine Prevents Contact Lens-Induced Myopia in Guinea Pigs. Invest. Ophthalmol. Vis. Sci. 2018;59(9):691.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Topical atropine is now widely used by pediatric optometrists and ophthalmologists for controlling myopia progression, however, the optimal dosing routine is yet to be determined. This study first examined the efficacy of topical 1% atropine applied daily and once per week for controlling myopia in pigmented guinea pigs.

Methods : Eighteen pigmented guinea pigs (New Zealand strain; 11 male, 7 female) wore -10D custom-made rigid gas-permeable contact lenses in one eye for two weeks for myopia induction. Eight animals were also treated with atropine daily, two with atropine once per week, and eight received topical artificial tears as a placebo control. The primary outcome measure is change in axial length AL), measured with the Lenstar in alert animals. Refractive errors were also measured with retinoscopy, and corneal curvatures were measured using anterior segment OCT and analyzed using a custom matlab software.

Results : While there were no significant differences between the 3 groups after one week of treatment, animals treated with daily atropine became significantly less myopic than the control group at the end of week 2 (AL, p = 0.04). However, at the latter timepoint, there was no significant difference between the control group and animals treated once per week (study of this group is ongoing). The attached figures show mean changes (+/-SEM) in axial length (Figure 1) and in refractive error (Figure 2).

Conclusions : Daily administration of 1% topical atropine slows myopia progression in pigmented guinea pigs, with a larger effect noted in the second week of treatment. The efficacy of weekly atropine is the subject of on-going investigation.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.




This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.